Home
Conditions
Biliary Tract Cancer

Clinical trial condition

Biliary Tract Cancer

Explore clinical trials studying Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.

168 public trials 56 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Cancer trial results

Active, not recruiting

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

NCT03482102

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy

NCT03631173

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Active, not recruiting

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

NCT05771480

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Research Site Mobile, Alabama, United States

Research Site Orange, California, United States

Research Site Washington D.C., District of Columbia, United States

Research Site Portland, Oregon, United States

View all 34 locations

View Trial Details

Active, not recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

NCT06178445

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
Locations: Universitätsklinikum Augsburg Augsburg, Germany

Charité Universitätsmedizin Berlin, Germany

Krankenhaus Nordwest (KHNW) Frankfurt, Germany

Universitätsklinikum Freiburg Freiburg im Breisgau, Germany

View Trial Details

Active, not recruiting

AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

NCT06591520

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Harbin Medical University Cancer Hospital Harbin, China

Zhongshan Hospital, Fudan University Shanghai, China

View Trial Details

Active, not recruiting

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

NCT06975917

Conditions: Biliary Tract Cancer, Biliary Tract Cancers (BTC), Biliary Tract Diseases, +5 more
Locations: Ankara University Faculty of Medicine Department of Medical Oncology Ankara, Turkey (Türkiye)

View Trial Details

Active, not recruiting

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

NCT03695952

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Changhoon Yoo Seoul, South Korea

View Trial Details

Active, not recruiting

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

NCT06490107

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Completed

Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

NCT05835778

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Research Site Aichi, Japan

Research Site Aomori, Japan

Research Site Chiba, Japan

Research Site Ehime, Japan

View all 24 locations

View Trial Details

Completed

XmAb20717 in Advanced Biliary Tract Cancers

NCT05297903

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Biliary Tract Cancer

Biliary Tract Cancer trial results

Related conditions